Now showing items 1-2 of 2

    • HIV/AIDS patients display lower relative bioavailability of Efavirenz than healthy subjects 

      Mukonzo, Jackson K; Nanzigu, Sara; Rekic, Dinko; Waako, Paul; Roshammar, Daniel; Ashton, Michael; Ogwal-Okeng, Jasper; Gustafsson, Lars L.; Aklillu, Eleni (Adis Data Information BV., 2011)
      Background: Pharmacokinetic studies of antiretroviral drugs are often conducted in adult healthy subjects, and the results are extrapolated to HIV/AIDS patients. HIV/AIDS, however, is known to cause morphological and ...
    • NeuroAIDS in Africa 

      Robertson, Kevin; Liner, Jeff; Hakim, James; Sankalé, Jean-Louis; Grant, Igor; Letendre, Scott; Clifford, David; Diop, Amadou Gallo; Jaye, Assan; Kanmogne, Georgette; Njamnshi, Alfred; Langford, T. Dianne; Weyessa, Tufa Gemechu; Wood, Charles; Banda, Mwanza; Hosseinipour, Mina; Sacktor, Nad; Nakasuja, Noeline; Bangirana, Paul; Paul, Robert; Joska, John; Wong, Joseph; Boivin, Michael; Holding, Penny; Kammerer, Betsy; Van Rie, Annelies; Ive, Prudence; Nath, Avindra; Lawler, Kathy; Adebamowo, Clement; Royal III, Walter; Joseph, Jeymohan (Informa Healthcare, 2010)
      In July 2009, the Center for Mental Health Research on AIDS at the National Institute of Mental Health organized and supported the meeting “NeuroAIDS in Africa.” This meeting was held in Cape Town, South Africa, and ...